Title: 17β-HSD2 inhibitors for the treatment of osteoporosis: Identification of a promising scaffold.
Journal: Bioorganic & medicinal chemistry 20110115
98966-14-4
1794817-30-3
5409-54-1
4933-19-1 | 5H-Pyrrolo[3,4-b]pyrazine-5,7(6h)-dione | AA00DKO9 | MFCD01686950
447406-53-3 | 1-[4-Methyl-2-(4-trifluoromethylphenyl)thiazol-5-yl]ethanone | AA00DL0U | MFCD13243230
54262-75-8 | 1-Azetidinepropanamine | AA00DLA1 | MFCD19159572
51934-45-3 | Ethyl 4-methyl-1-naphthoate | AA00DLMA | MFCD06204668
54232-58-5 | 9-oxo-10(E),12(E)-Octadecadienoic Acid | AA00DLYJ
473798-59-3 | 5-Amino-2,3-dihydro-2-(1-methylethyl)-4-(2-methylphenyl)-3-oxo-1H-pyrazole-1-carbothioic acid S-2-propen-1-yl ester | AA00DNCK | MFCD23103560
558443-53-1 | [1-(2-Hydroxy-ethyl)-piperidin-4-yl]-carbamic acid tert-butyl ester | AA00DPCL | MFCD04035723
4465-04-7 | Butanoic acid, 3-Methyl-2-Methylene- | AA00DQU8 | MFCD19228087
53616-17-4 | 4-[4-(ethoxycarbonyl)anilino]-4-oxobut-2-enoic acid | AA00DTCG | MFCD00063173
497-56-3 | 2-Methyl-3,5-dinitrophenol | AA00DVBT | MFCD00024482
